{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:17:54Z","timestamp":1783023474378,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012304","name":"School of Medicine, Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009779","name":"Johns Hopkins Greenberg Bladder Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.yexmp.2026.105032","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:54:16Z","timestamp":1770663256000},"page":"105032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular characterization of non-muscle invasive tumor from N-methyl-N-nitrosourea (MNU)-induced urothelial carcinoma in a rat model reveals hallmarks of both luminal and basal subtypes"],"prefix":"10.1016","volume":"145","author":[{"given":"Kara A.","family":"Lombardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S.","family":"Baras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity J.","family":"Bivalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yexmp.2026.105032_bb0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/path.1559","article-title":"Expression of luminal and basal cytokeratins in human breast carcinoma","volume":"203","author":"Abd El-Rehim","year":"2004","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105032_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105032_bb0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2017.03.010","article-title":"Genetic alterations in the Molecular subtypes of Bladder Cancer: illustration in the Cancer genome atlas dataset","volume":"72","author":"Choi","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.yexmp.2026.105032_bb0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-analysis of the luminal and basal subtypes of Bladder Cancer and the identification of signature immunohistochemical markers for clinical use","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.yexmp.2026.105032_bb0025","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2026.105032_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"6322","key":"10.1016\/j.yexmp.2026.105032_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"issue":"697","key":"10.1016\/j.yexmp.2026.105032_bb0040","doi-asserted-by":"crossref","first-page":"eabn4118","DOI":"10.1126\/scitranslmed.abn4118","article-title":"Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin","volume":"15","author":"de Jong","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-019-02146-5","article-title":"The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice","volume":"17","author":"Degoricija","year":"2019","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105032_bb0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41385-022-00549-0","article-title":"The impact of biological sex on diseases of the urinary tract","volume":"15","author":"Deltourbe","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions","volume":"12","author":"Doshi","year":"2023","journal-title":"Oncogenesis"},{"issue":"Suppl. 2","key":"10.1016\/j.yexmp.2026.105032_bb0060","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/modpathol.2008.235","article-title":"The current classification of urothelial neoplasms","volume":"22","author":"Grignon","year":"2009","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.annonc.2024.09.008","article-title":"Basal\/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial","volume":"36","author":"Groeneveld","year":"2025","journal-title":"Ann. Oncol."},{"issue":"18","key":"10.1016\/j.yexmp.2026.105032_bb0070","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0075","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1038\/s41598-020-66747-7","article-title":"Assessment of luminal and basal phenotypes in Bladder Cancer","volume":"10","author":"Guo","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105032_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.5250","article-title":"Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy","volume":"248","author":"Heide","year":"2019","journal-title":"J. Pathol."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105032_bb0090","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-11-3195","article-title":"Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer","volume":"72","author":"Ho","year":"2012","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105032_bb0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PAI.0000000000000938","article-title":"Expression of Nectin-4 in Bladder urothelial carcinoma, in morphologic variants, and nonurothelial Histotypes","volume":"29","author":"Hoffman-Censits","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105032_bb0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus Molecular classification of muscle-invasive Bladder Cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"issue":"21","key":"10.1016\/j.yexmp.2026.105032_bb0105","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1158\/1078-0432.CCR-17-1082","article-title":"Preclinical evaluation of intravesical cisplatin nanoparticles for non-muscle-invasive Bladder Cancer","volume":"23","author":"Kates","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105032_bb0110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/2326-6066.CIR-16-0267","article-title":"Intravesical BCG induces CD4+ T-cell expansion in an immune competent model of Bladder Cancer","volume":"5","author":"Kates","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105032_bb0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of Bladder Cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0130","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105032_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.5830","article-title":"BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer","volume":"256","author":"Lombardo","year":"2022","journal-title":"J. Pathol."},{"issue":"244","key":"10.1016\/j.yexmp.2026.105032_bb0140","doi-asserted-by":"crossref","first-page":"244ra291","DOI":"10.1126\/scitranslmed.3008970","article-title":"EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype","volume":"6","author":"Rebouissou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexmp.2026.105032_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive Molecular characterization of muscle-invasive Bladder Cancer","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"10031","key":"10.1016\/j.yexmp.2026.105032_bb0150","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.yexmp.2026.105032_bb0155","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/0008-5472.CAN-18-0173","article-title":"Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy","volume":"78","author":"Saito","year":"2018","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105032_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ncb2956","article-title":"Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma","volume":"16","author":"Shin","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0165","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-022-28509-z","article-title":"Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer","volume":"13","author":"Singh","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105032_bb0170","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","article-title":"A molecular taxonomy for urothelial carcinoma","volume":"18","author":"Sjodahl","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105032_bb0175","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ajpath.2013.05.013","article-title":"Toward a molecular pathologic classification of urothelial carcinoma","volume":"183","author":"Sjodahl","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4886","article-title":"Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification","volume":"242","author":"Sjodahl","year":"2017","journal-title":"J. Pathol."},{"issue":"20","key":"10.1016\/j.yexmp.2026.105032_bb0185","first-page":"6668","article-title":"Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model","volume":"50","author":"Steinberg","year":"1990","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105032_bb0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/2326-6066.CIR-15-0274","article-title":"Molecular drivers of the non-T-cell-inflamed tumor microenvironment in urothelial Bladder Cancer","volume":"4","author":"Sweis","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0195","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1038\/s41467-021-26421-6","article-title":"Pparg signaling controls bladder cancer subtype and immune exclusion","volume":"12","author":"Tate","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105032_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3038","article-title":"Bladder cancers arise from distinct urothelial sub-populations","volume":"16","author":"Van Batavia","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105032_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","article-title":"Intratumoral heterogeneity of Bladder Cancer by Molecular subtypes and histologic variants","volume":"75","author":"Warrick","year":"2019","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105032_bb0210","doi-asserted-by":"crossref","first-page":"160 e123","DOI":"10.1016\/j.urolonc.2017.11.024","article-title":"Ex vivo culture of tumor cells from N-methyl-N-nitrosourea-induced bladder cancer in rats: development of organoids and an immortalized cell line","volume":"36","author":"Yoshida","year":"2018","journal-title":"Urol. Oncol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:37:14Z","timestamp":1783021034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S0014480026000110"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105032","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of non-muscle invasive tumor from N-methyl-N-nitrosourea (MNU)-induced urothelial carcinoma in a rat model reveals hallmarks of both luminal and basal subtypes","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105032"}}